Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

InterMune, Inc. (NASDAQ:ITMN.DL)

CAPS Rating: No stars

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITMN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SkepBioInvestor (< 20)
Submitted February 09, 2014

Positive ASCEND data

Reply | Report this Post

asabah (< 20)
Submitted June 28, 2007

Finding a single compound as an inhibitor of Hepititis C virus (HCV) is not an easy task. HCV has 6 different genotypes and within each genotype there are a number of subtypes. It is an RNA virus which mutates very quickly. Therefore in a single… More

1 Reply | Report this Post

NASDAQ:ITMN.DL Summary

  • Sector:
    • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ITMN.DL.

No one has written a Pitch for ITMN.DL stock yet. Tell us why you think ITMN.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ITMN.DL.

No players have picked ITMN.DL yet. Tell us why you think ITMN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITMN.DL.